Multiple sclerosis drug Gilenya may provide a clue for new PTSD therapy
Multiple sclerosis drug Gilenya may provide a clue for possible new PTSD therapy. Based on the study conducted on mice, the researchers uncovered a new therapeutic approach to treating post-traumatic stress disorder (PTSD). Gilenya is a sphingosine-1-phosphate-receptor modulator, which is commonly used as a treatment for multiple sclerosis. The researchers found that fingolimod (a generic ...click here to read more






